Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Étude NATALEE : étude de phase 3, randomisée, évaluant l'efficacité et la tolérance du ribociclib associé à un traitement endocrine, comme traitement adjuvant, chez des patients ayant un cancer du sein HR+/HER2-. https://www.kusajili.fr:443/Trial/EiKHo0qBKkiKnK70ha4Prw%24etude-natalee-etude-de-phase-3-randomisee-evaluant-lefficacite-et-la-tolerance-du-ribociclib-associe-a-un-traitement-endocrine-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message